FloodLAMP is developing a cooperative, open approach to revolutionize diagnostics in service of the greatest positive impact on the COVID crisis and public health, both nationally and globally.
Our program is designed to repeatedly screen interacting groups through molecular tests that:
- cost less than $1 per person;
- enable a single basic lab to screen 50,000 people/day;
- have high sensitivity to reliably identify new infections early;
- minimize spread and stops outbreaks;
- drive down disease prevalence, enabling a return to economic growth and a thriving society.